Human Reproduction

Papers
(The H4-Index of Human Reproduction is 42. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Reply: Non-inferior or not inferior, it is more than semantics274
P-622 Prospectively randomized study of intraovarian injections of autologous platelet-rich plasma (PRP) into one alternating ovary in Primary Ovarian Insufficiency (POI)204
O-026 Development of deep learning-based model for differential diagnosis of ovarian neoplasm using pelvic ultrasonography150
O-096 Effect of Day-3 embryo morphology on blastocyst quality and ploidy: a machine-learning model of 34781 embryos148
O-242 ADAPT-1: A multicentre, randomised, assessor-blind comparison of ovarian stimulation with follitropin delta versus follitropin alfa for in vitro fertilisation using conventional dosing regimens146
O-288 Implantation, ultrastructure and metabolic profiling of embryos from PGT-M and PGT-A Cycles135
P-290 Isolation and characterization of extracellular vesicles from human endometrial organoids118
P-376 Oocyte accumulation program in young women at high risk of ovarian injury due to endometriomas or benign ovarian tumors: intermediate results from a prospective study89
P-337 Does Endometriosis Have More Detrimental Effect on Ovarian Reserve in the Presence of Autoimmunity? A Prospective Observational Study74
P-507 Evaluating quantitative PCR for vaginal microbiome profiling: a high-accuracy, low-cost alternative to sequencing for research and clinical applications73
P-531 Effectiveness and safety of uterine septum division: An updated systematic review and meta-analysis72
O-076 Novel method to enhance preantral follicle growth by granulocyte colony-stimulating factor administration improves embryos and pregnancy rate in poor ovarian reserve: a randomized controlled tri64
P-682 Androgen and Inhibin B levels during ovarian stimulation before and after eight weeks of low dose hCG priming in women with low ovarian reserve64
P-704 Distinctive proteomic profiling and pathway analysis of plasma extracellular vesicles provided clues for their regulatory roles in the pathogenesis of polycystic ovarian syndrome61
P-193 Prediction of blastocyst ploidy from 2,438 images of mature oocytes using an artificial intelligence (AI)-based algorithm: a validation study60
P-198 Evolution of artificial intelligence-based embryo selection models: a massive external validation on 70,456 embryos59
O-015 Spontaneous alterations in semen parameters are associated with age, accessory gland function and the FSHB c.-211G>T variant58
P-309 Injectable “homing-like” bioactive short-fibers for endometrial repair and efficient live births57
P-547 Recurrent miscarriage and the risks of stroke and type II diabetes later in life: a Mendelian randomization analysis56
P-253 Determination of age-specific diagnostic criteria for OZEMA (Oocyte/Zygote/Embryo Maturation Arrest) phenotypes based on 16,994 cycles55
P-365 High Impact of Chemotherapy on Ovarian Reserve in Breast Cancer Survivors of Reproductive Age: A Systematic Review and Meta-Analysis53
P-550 Monoallelic CCNB2 variants may cause oocyte maturation defects and embryo developmental arrest52
P-736 Balanced cryptic chromosomal rearrangement carriers detection by optical genome mapping (OGM)51
P-648 Association of severity of menstrual dysfunction with cardiometabolic risk markers in polycystic ovary syndrome50
P-086 Consequences of elevated levels of DNA fragmentation and its influence on pregnancy – A multicentric cohort analysis50
P-092 PGT-A Evaluates Advanced Sperm Selection in Embryos from High Teratozoospermia Males; a prospective randomized controlled trial48
P-403 Oocyte usage and disposition outcomes following oocyte cryopreservation48
P-441 Clinical results from a double ovarian stimulation protocol involving follicular and a subsequent luteal phase stimulation in poor reproductive prognosis patients47
O-018 Utilisation of second successive ejaculate as a way to overcome poor semen parameters for couples who wish to undergo conventional-IVF47
P-649 Unconventional action of Luteinizing Hormone46
O-143 Biopsy-free profiling of the uterine immune system in patients with recurrent pregnancy loss and unexplained infertility46
P-473 Adenomyosis progression over time in patients with repeated pregnancy loss: ultrasound-based observations46
Correction to: Pregnancy outcomes with increasing maternal age, greater than 40 years, in donor oocyte cycles45
O-053 Link between cannabis use and fertility: effects on gamete competence and early embryonic development45
P-695 Unveiling the Hidden Markers of Oocyte Quality: Proteomics Analysis in PCOS patients44
P-779 18-year follow-up of 609 children born after oocyte donation: comparison with IVF and spontaneous conception based on a national health registry44
P-601 Deciding ‘THE most appropriate day’ of trigger for retrieving mature oocytes in IVF Cycles: Serum Plasminogen Activator Inhibitor-1, a robust prognostic bio-arbitrator decodes this dilemma44
P-133 Cytoplasmic strings between inner cell mass and trophectoderm: novel predictors of euploid blastocysts’ implantation competence44
O-266 Multi-omics landscape of uterine fluid-derived extracellular vesicles across the menstrual cycle43
P-735 Is Artificial Intelligence (AI) currently able to provide evidence-based scientific responses on methods that can improve the outcomes of embryo transfers?43
P-380 Improvement of follicle growth and health during dynamic culture of bovine ovarian cortical tissue (BOCT) is associated to a higher remodeling of the extracellular matrix43
P-200 Tailoring IVF laboratory key performance indicators of the Vienna consensus in testicular sperm aspiration cases42
P-247 Equivalence observed in fertilisation rates between microICSI, a new ICSI tool, and conventional ICSI. The first evaluation of microICSI fertilisation of human oocytes42
0.096648931503296